Biotechnology Product Manufacturing

Biotechnology Product Manufacturing

Brief Excerpt from Industry Overview Chapter:

Companies in this industry manufacture vaccines, toxoids, blood fractions, and culture media of plant or animal origin. Major companies include Amgen, Biogen, Genentech, and Gilead Sciences (all based in the US), as well as Bayer and Merck Group (both based in Germany), CSL (Australia), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France).

COMPETITIVE LANDSCAPE

Biotech firms face stiff competition from major pharmaceutical manufacturers and other companies seeking to be first with a new product or discovery. Development is often focused on high-demand, profitable markets such as cancer or rare disease treatment. Biopharmaceutical companies depend on gaining regulatory and insurance coverage approval for new treatments. They may also count on participation in government research or expedited approval programs.

PRODUCTS, OPERATIONS & TECHNOLOGY

Major products of biotechnology product manufacturers include biologics, which account for about 30% of the industry's revenue. This is followed by blood and blood derivatives accounting for about 10% of the industry revenue. Other products and services include pharmaceutical preparations, and chemical contract manufacturing, account for about 60% of the industry revenue.